BFM
TNDM icon

Boothbay Fund Management’s Tandem Diabetes Care TNDM Stock Holding History

Boothbay Fund Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,250
Closed -$816K – 1942
2024
Q2 		$816K Buy
20,250
+12,700
+168% +$530K 0.02% 794
2024
Q1 		$267K Sell
7,550
-9,866
-57% -$264K 0.01% 1233
2023
Q4 		$515K Buy
+17,416
New +$361K 0.01% 978
2023
Q1 		– Sell
-8,503
Closed -$382K – 2496
2022
Q4 		$382K Buy
+8,503
New +$385K 0.01% 1282
2022
Q3 		– Sell
-4,416
Closed -$261K – 2602
2022
Q2 		$261K Buy
+4,416
New +$363K 0.01% 1559
2021
Q4 		– Sell
-2,714
Closed -$324K – 2229
2021
Q3 		$324K Buy
2,714
+178
+7% +$19.6K 0.01% 1294
2021
Q2 		$247K Sell
2,536
-1,918
-43% -$171K 0.01% 1399
2021
Q1 		$393K Buy
+4,454
New +$414K 0.01% 1070
2019
Q2 		– Sell
-3,910
Closed -$252K – 893
2019
Q1 		$248K Buy
+3,910
New +$205K 0.02% 555
2018
Q2 		– Sell
-21,000
Closed -$104K – 890
2018
Q1 		$104K Buy
+21,000
New +$67.7K 0.01% 644

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's TNDM Position: Q3 2024 in Review

Boothbay Fund Management sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 20,250 shares — an estimated $816K sold.

Boothbay Fund Management first reported a position in TNDM in Q1 2018 and held it in 10 quarters. The position peaked at $816K in Q2 2024. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Boothbay Fund Management reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 20,250 Tandem Diabetes Care shares in Q3 2024, an estimated $816K.
  • Boothbay Fund Management first reported a position in Tandem Diabetes Care in Q1 2018 and held it in 10 quarters.
  • Boothbay Fund Management's Tandem Diabetes Care position peaked at $816K in Q2 2024.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Boothbay Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.